283 related articles for article (PubMed ID: 11422039)
1. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris.
Spaeth S; Riechers R; Borradori L; Zillikens D; Büdinger L; Hertl M
Br J Dermatol; 2001 Jun; 144(6):1183-8. PubMed ID: 11422039
[TBL] [Abstract][Full Text] [Related]
2. Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3.
Nagel A; Lang A; Engel D; Podstawa E; Hunzelmann N; de Pita O; Borradori L; Uter W; Hertl M
Clin Immunol; 2010 Mar; 134(3):320-30. PubMed ID: 20015693
[TBL] [Abstract][Full Text] [Related]
3. A study of desmoglein 1 autoantibodies in pemphigus vulgaris: racial differences in frequency and the association with a more severe phenotype.
Harman KE; Gratian MJ; Bhogal BS; Challacombe SJ; Black MM
Br J Dermatol; 2000 Aug; 143(2):343-8. PubMed ID: 10951143
[TBL] [Abstract][Full Text] [Related]
4. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives.
Kricheli D; David M; Frusic-Zlotkin M; Goldsmith D; Rabinov M; Sulkes J; Milner Y
Br J Dermatol; 2000 Aug; 143(2):337-42. PubMed ID: 10951142
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of IgA antibodies to desmogleins 1 and 3 in pemphigus vulgaris, pemphigus foliaceus and paraneoplastic pemphigus.
Mentink LF; de Jong MC; Kloosterhuis GJ; Zuiderveen J; Jonkman MF; Pas HH
Br J Dermatol; 2007 Apr; 156(4):635-41. PubMed ID: 17263817
[TBL] [Abstract][Full Text] [Related]
6. Dichotomy of autoreactive Th1 and Th2 cell responses to desmoglein 3 in patients with pemphigus vulgaris (PV) and healthy carriers of PV-associated HLA class II alleles.
Veldman C; Stauber A; Wassmuth R; Uter W; Schuler G; Hertl M
J Immunol; 2003 Jan; 170(1):635-42. PubMed ID: 12496453
[TBL] [Abstract][Full Text] [Related]
7. Predominant IgG4 subclass in autoantibodies of pemphigus vulgaris and foliaceus.
Futei Y; Amagai M; Ishii K; Kuroda-Kinoshita K; Ohya K; Nishikawa T
J Dermatol Sci; 2001 May; 26(1):55-61. PubMed ID: 11323221
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous immunolocalization of desmoglein 3 and IgG4 in oral pemphigus vulgaris: IgG4 predominant autoantibodies in its pathogenesis.
Abé T; Maruyama S; Babkair H; Yamazaki M; Cheng J; Saku T
J Oral Pathol Med; 2015 Nov; 44(10):850-6. PubMed ID: 25401705
[TBL] [Abstract][Full Text] [Related]
9. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile.
Amagai M; Tsunoda K; Zillikens D; Nagai T; Nishikawa T
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 1):167-70. PubMed ID: 10025740
[TBL] [Abstract][Full Text] [Related]
10. Serum and salivary IgG and IgA antibodies to desmoglein 3 in mucosal pemphigus vulgaris.
Ali S; Kelly C; Challacombe SJ; Donaldson AN; Bhogal BS; Setterfield JF
Br J Dermatol; 2016 Jul; 175(1):113-21. PubMed ID: 26799252
[TBL] [Abstract][Full Text] [Related]
11. IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis.
Christophoridis S; Büdinger L; Borradori L; Hunziker T; Merk HF; Hertl M
Br J Dermatol; 2000 Aug; 143(2):349-55. PubMed ID: 10951144
[TBL] [Abstract][Full Text] [Related]
12. Conformational epitope mapping and IgG subclass distribution of desmoglein 3 in paraneoplastic pemphigus.
Futei Y; Amagai M; Hashimoto T; Nishikawa T
J Am Acad Dermatol; 2003 Dec; 49(6):1023-8. PubMed ID: 14639380
[TBL] [Abstract][Full Text] [Related]
13. Isotypes and antigenic profiles of pemphigus foliaceus and pemphigus vulgaris autoantibodies.
Hacker MK; Janson M; Fairley JA; Lin MS
Clin Immunol; 2002 Oct; 105(1):64-74. PubMed ID: 12483995
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic IgG antibodies against desmoglein 3 in pemphigus vulgaris are regulated by HLA-DRB1*04:02-restricted T cells.
Eming R; Hennerici T; Bäcklund J; Feliciani C; Visconti KC; Willenborg S; Wohde J; Holmdahl R; Sønderstrup G; Hertl M
J Immunol; 2014 Nov; 193(9):4391-9. PubMed ID: 25252957
[TBL] [Abstract][Full Text] [Related]
15. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris.
Müller R; Svoboda V; Wenzel E; Gebert S; Hunzelmann N; Müller HH; Hertl M
Exp Dermatol; 2006 Aug; 15(8):606-14. PubMed ID: 16842599
[TBL] [Abstract][Full Text] [Related]
16. Antibodies against keratinocyte antigens other than desmogleins 1 and 3 can induce pemphigus vulgaris-like lesions.
Nguyen VT; Ndoye A; Shultz LD; Pittelkow MR; Grando SA
J Clin Invest; 2000 Dec; 106(12):1467-79. PubMed ID: 11120754
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the T cells that are potentially involved in autoantibody production in pemphigus vulgaris.
Hertl M; Riechers R
J Dermatol; 1999 Nov; 26(11):748-52. PubMed ID: 10635617
[TBL] [Abstract][Full Text] [Related]
18. A pathogenic autoantibody, pemphigus vulgaris-IgG, induces phosphorylation of desmoglein 3, and its dissociation from plakoglobin in cultured keratinocytes.
Aoyama Y; Owada MK; Kitajima Y
Eur J Immunol; 1999 Jul; 29(7):2233-40. PubMed ID: 10427986
[TBL] [Abstract][Full Text] [Related]
19. Keratin Retraction and Desmoglein3 Internalization Independently Contribute to Autoantibody-Induced Cell Dissociation in Pemphigus Vulgaris.
Schlögl E; Radeva MY; Vielmuth F; Schinner C; Waschke J; Spindler V
Front Immunol; 2018; 9():858. PubMed ID: 29922278
[No Abstract] [Full Text] [Related]
20. Desmoglein 3-ELISA: a pemphigus vulgaris-specific diagnostic tool.
Lenz P; Amagai M; Volc-Platzer B; Stingl G; Kirnbauer R
Arch Dermatol; 1999 Feb; 135(2):143-8. PubMed ID: 10052398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
